Could a Low-Dose drug ease debilitating long COVID fatigue?
Symptom relief
Completed
This study tested whether a low dose of the drug naltrexone (LDN) could reduce severe fatigue and improve quality of life for people with Post-COVID Fatigue Syndrome, a form of Long COVID. In this completed Phase 2 trial, 160 participants were randomly assigned to take either LDN…
Phase: PHASE2 • Sponsor: Luis Nacul • Aim: Symptom relief
Last updated Apr 04, 2026 11:36 UTC